நிறுவனம் க்கு மூலக்கூறு மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் க்கு மூலக்கூறு மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் க்கு மூலக்கூறு மருந்து Today - Breaking & Trending Today

Investegate |BioNTech SE Announcements | BioNTech SE: BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science


BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA vaccine encoding disease-related autoantigens that suppressed disease activity in several complex mouse models of multiple sclerosis
Approach addresses key pitfalls in the treatment of autoimmune diseases such as the induction of systemic immune suppression
Approach can easily be tailored to individual disease-causing antigens of patients and confers bystander tolerance to address highly complex, polyclonal and rare autoimmune disease types
Represents the first application of BioNTech’s mRNA technology for the purpose of antigen-specific immune-modulation of autoimmune diseases, which further expands BioNTech’s diversified immunology pipeline into another category of disease r ....

Sylke Maas , Stabsstelle Unternehmenskommunikation , Fosun Pharma , Johannes Gutenberg University Mainz , University Medical Center , Research Center , Bayer Animal Health , Institute For Molecular Medicine , Roche Group , Immunotherapy At Johannes Gutenberg University Of Mainz , University Medical Center Mainz Contact , Publishes Data , Treat Autoimmune Diseases , Johannes Gutenberg University , Translational Oncology , Molecular Medicine , New Technologies , Forward Looking Statements , Private Securities Litigation Reform Act , Quarterly Report , Nine Months Ended September , Current Report , பல்கலைக்கழகம் மருத்துவ மையம் , ஆராய்ச்சி மையம் , பேயர் விலங்கு ஆரோக்கியம் , நிறுவனம் க்கு மூலக்கூறு மருந்து ,

BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SEJanuary 7, 2021 GMT
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA vaccine encoding disease-related autoantigens that suppressed disease activity in several complex mouse models of multiple sclerosis
Approach addresses key pitfalls in the treatment of autoimmune diseases such as the induction of systemic immune suppression
Approach can easily be tailored to individual disease-causing antigens of patients and confers bystander tolerance to address highly complex, polyclonal and rare autoimmune disease types ....

Sylke Maas , Stabsstelle Unternehmenskommunikation , Fosun Pharma , Johannes Gutenberg University Mainz , University Medical Center , Research Center , Bayer Animal Health , Institute For Molecular Medicine , Roche Group , Immunotherapy At Johannes Gutenberg University Of Mainz , University Medical Center Mainz Contact , Johannes Gutenberg University , Translational Oncology , Molecular Medicine , New Technologies , Forward Looking Statements , Private Securities Litigation Reform Act , Quarterly Report , Nine Months Ended September , Current Report , பல்கலைக்கழகம் மருத்துவ மையம் , ஆராய்ச்சி மையம் , பேயர் விலங்கு ஆரோக்கியம் , நிறுவனம் க்கு மூலக்கூறு மருந்து , ரோச் குழு , ஜோஹன்னஸ் குட்டன்பெர்க் பல்கலைக்கழகம் ,